These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 30793550)

  • 21. Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany.
    Labenz C; Huber Y; Kalliga E; Nagel M; Ruckes C; Straub BK; Galle PR; Wörns MA; Anstee QM; Schuppan D; Schattenberg JM
    Aliment Pharmacol Ther; 2018 Nov; 48(10):1109-1116. PubMed ID: 30288767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and management of non-alcoholic fatty liver disease.
    Jennison E; Patel J; Scorletti E; Byrne CD
    Postgrad Med J; 2019 Jun; 95(1124):314-322. PubMed ID: 31085617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
    Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
    Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts.
    Papatheodoridi M; Cholongitas E
    Curr Pharm Des; 2018; 24(38):4574-4586. PubMed ID: 30652642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?
    Mikolasevic I; Orlic L; Franjic N; Hauser G; Stimac D; Milic S
    World J Gastroenterol; 2016 Aug; 22(32):7236-51. PubMed ID: 27621571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic fatty liver disease: Evolving paradigms.
    Lonardo A; Nascimbeni F; Maurantonio M; Marrazzo A; Rinaldi L; Adinolfi LE
    World J Gastroenterol; 2017 Sep; 23(36):6571-6592. PubMed ID: 29085206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An association of large-fibre peripheral nerve dysfunction with non-invasive measures of liver fibrosis secondary to non-alcoholic fatty liver disease in diabetes.
    Williams KH; Burns K; Constantino M; Shackel NA; Prakoso E; Wong J; Wu T; George J; McCaughan GW; Twigg SM
    J Diabetes Complications; 2015; 29(8):1240-7. PubMed ID: 26297218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Hannah WN; Harrison SA
    Hepatology; 2016 Dec; 64(6):2234-2243. PubMed ID: 27338123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective.
    Rhee EJ
    Endocrinol Metab (Seoul); 2019 Sep; 34(3):226-233. PubMed ID: 31565874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic.
    Ismail MH
    Am J Med Sci; 2011 Jun; 341(6):485-92. PubMed ID: 21412139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods.
    Yoneda M; Imajo K; Takahashi H; Ogawa Y; Eguchi Y; Sumida Y; Yoneda M; Kawanaka M; Saito S; Tokushige K; Nakajima A
    J Gastroenterol; 2018 Feb; 53(2):181-196. PubMed ID: 29177681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic fatty liver disease - A multisystem disease?
    Mikolasevic I; Milic S; Turk Wensveen T; Grgic I; Jakopcic I; Stimac D; Wensveen F; Orlic L
    World J Gastroenterol; 2016 Nov; 22(43):9488-9505. PubMed ID: 27920470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors.
    Prasetya IB; Hasan I; Wisnu W; Rumende CM
    Acta Med Indones; 2017 Apr; 49(2):91-98. PubMed ID: 28790222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes.
    Cusi K; Sanyal AJ; Zhang S; Hartman ML; Bue-Valleskey JM; Hoogwerf BJ; Haupt A
    Diabetes Obes Metab; 2017 Nov; 19(11):1630-1634. PubMed ID: 28417532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-alcoholic fatty liver disease in pediatric type 2 diabetes: Metabolic and histologic characteristics in 38 subjects.
    Newfield RS; Graves CL; Newbury RO; Schwimmer JB; Proudfoot JA; Say DS; Feldstein AE
    Pediatr Diabetes; 2019 Feb; 20(1):41-47. PubMed ID: 30467936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Prevalence of Nonalcoholic Fatty Liver Disease and Its Risk Factors in Children and Young Adults with Type 1 Diabetes Mellitus.
    Sae-Wong J; Chaopathomkul B; Phewplung T; Chaijitraruch N; Sahakitrungruang T
    J Pediatr; 2021 Mar; 230():32-37.e1. PubMed ID: 33250172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
    Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
    Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.
    Targher G; Valbusa F; Bonapace S; Bertolini L; Zenari L; Pichiri I; Mantovani A; Zoppini G; Bonora E; Barbieri E; Byrne CD
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):663-9. PubMed ID: 24594085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.
    Doycheva I; Cui J; Nguyen P; Costa EA; Hooker J; Hofflich H; Bettencourt R; Brouha S; Sirlin CB; Loomba R
    Aliment Pharmacol Ther; 2016 Jan; 43(1):83-95. PubMed ID: 26369383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.